Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

BACKGROUND: Optimal antimicrobial drug exposure in the lung is required for successful treatment outcomes for nosocomial pneumonia. Little is known about the intrapulmonary pharmacokinetics (PK) of meropenem when administered by continuous infusion (CI). The aim of this study was to evaluate the PK...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Crit Care
Autors principals: Benítez-Cano, Adela, Luque, Sonia, Sorlí, Luisa, Carazo, Jesús, Ramos, Isabel, Campillo, Nuria, Curull, Víctor, Sánchez-Font, Albert, Vilaplana, Carles, Horcajada, Juan P., Adalia, Ramón, Bermejo, Silvia, Samsó, Enric, Hope, William, Grau, Santiago
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026992/
https://ncbi.nlm.nih.gov/pubmed/32066497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-2763-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars